NXO.V - NexOptic Technology Corp.

TSXV - TSXV Real Time Price. Currency in CAD
0.0000 (0.00%)
As of 11:10AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.0550
Bid0.0550 x 0
Ask0.0600 x 0
Day's Range0.0550 - 0.0650
52 Week Range0.0500 - 0.2300
Avg. Volume217,017
Market Cap10.737M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    NexOptic Announces Results from Internal Netflix Benchmark Testing of NexCompress™ LIVE NexCompress™ Demonstration at 1:15 PM PST Today

    ("NexOptic") (TSXV: NXO) (OTCQB: NXOPF) (FSE: E3O1), a company developing cutting-edge AI and imaging technologies, today announced the results from its internal testing of NexCompress, its flagship video compression AI technology. NexOptic also reports that it is hosting a LIVE demonstration of NexCompress™ at 1:15, PST today. Interested parties can access the event here: NexCompressLIVEbroadcast

  • CNW Group

    NexOptic Announces LIVE Demonstration of NexCompress™ AI Video Compression

    ("NexOptic") (TSXV: NXO) (OTCQB: NXOPF) (FSE: E3O1) is excited to announce a LIVE demonstration of NexCompress™, the company's proprietary AI for video compression. NexCompress is part of NexOptic's ALIIS™ suite of artificial intelligence imaging solutions. It enables significant bandwidth reduction of videos while operating either on edge devices, or in the cloud. It is complementary to, and in fact can, supercharge existing CODEC methods currently used by large video streaming companies like N

  • CNW Group

    NexOptic Technology Corp. Signs MOU with IntroMedic, A Global Capsule Endoscopic Imaging Corporation

    ("NexOptic") (TSXV: NXO) (OTCQB: NXOPF) (FSE: E3O1) and ("IntroMedic") jointly announce that they have entered a non-binding memorandum of understanding ("MOU"). IntroMedic is a leading innovator in global capsule endoscopy technology and medical imaging analysis whose objective is to always improve the quality of its patented imaging and analysis medical offerings. Further detail can be found on IntroMedic's website: IntroMedic

  • CNW Group

    NexOptic Announces NexCompress™ Commercialization Dual Rollout Strategy

    ("NexOptic") (TSXV: NXO) (OTCQB: NXOPF) (FSE: E3O1) announces a dual rollout strategy on the commercialization of Nexcompress.™ NexCompress is part of NexOptic's ALIIS™ suite of artificial intelligence imaging solutions and enables significant bandwidth reduction when coupled with existing video compression technologies.

  • CNW Group

    NexOptic Provides 2023 Outlook

    NexOptic Technology Corp. ("NexOptic" or the "Company") (TSXV: NXO) (OTCQB: NXOPF) (FSE: E3O1) updates shareholders on its outlook for 2023.

  • CNW Group

    Incentive Option Re-Pricing

    NexOptic Technology Corp. ("NexOptic") (TSXV: NXO) (OTCQB: NXOPF) (FSE: E3O1) announces that its Board of Directors has approved the repricing of a total of 16,830,000 stock options of the Company from original exercise prices ranging from $0.36 per share to $1.00 per share to [$0.10] per common share (collectively, the "Options"). All other terms of the Options will remain the same.

  • CNW Group

    Rich Geruson, NexOptic Chairman, Announces Closing of $2.2 Million Private Placement

    NexOptic Technology Corp. ("NexOptic") (TSXV: NXO) (OTCQB: NXOPF) (FSE: E3O1) announces the closing of its non-brokered private placement (the "Placement") previously announced on October 21, 2022. The Placement consists of an aggregate of 39,564,053 Units generating gross proceeds of $2,225,477.98. Each Unit comprised one common share of the Company plus one share purchase warrant (a "Warrant"). Each Warrant entitles the holder to acquire one common share of the Company at an exercise price of

  • CNW Group

    Rich Geruson, NexOptic Chairman, Announces 3.2M Non-Brokered Private Placement

    ("NexOptic") (TSXV: NXO) (OTCQB: NXOPF) (FSE: E3O1) announces that it intends to raise, on a non-brokered basis, aggregate gross proceeds of up to $3,220,000 through the issuance up to 57,250,000 units (each a "Unit") at a price of $0.05625 per Unit (the "Financing"). Each Unit will comprise one common share and one share purchase warrant. Each whole warrant (a "Warrant") will entitle the holder to acquire an additional common share at a price of $0.12 per share for a period of 2 years.

  • CNW Group

    Rich Geruson, NexOptic Chairman, Announces Appointment of New Chief Financial Officer

    NexOptic Technology Corp. ("NexOptic") (TSXV: NXO) (OTCQB: NXOPF) (FSE: E3O1) is very pleased to report that Mr. Chulhyun ("Wayne") Cho is joining as its new Chief Financial Officer. Mr. Cho brings a wealth of experience in finance and accounting to the team, including 8 years with Deloitte & Touche LLP ("Deloitte") where he led various assurance and consulting projects for different types of corporate clients of varying sizes during his tenure. He subsequently served as the head of finance for